# Ketamine- Propofol Versus Pethidine- Propofol in ERCP

> **NCT02651792** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 50 (actual)

## Conditions studied

- Sedation in ERCP

## Interventions

- **DRUG:** ketamine- propofol
- **DRUG:** pethidine- propofol

## Key facts

- **NCT ID:** NCT02651792
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651792, "Ketamine- Propofol Versus Pethidine- Propofol in ERCP". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02651792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
